[ORGANIZATION]
Stifel
Featured in 3 tracked stories · first seen
Situations
Braveheart Bio initial public offering
2 clusters · 4 sources · last updated
Latest: Braveheart Bio completes $382M IPO amid insider stock purchases
Braveheart Bio Inc., a biopharmaceutical company focused on therapeutics for hypertrophic cardiomyopathy and other cardiovascular diseases, initiated its initial public offering on the Nasdaq Global Market. The company u
Also covered in
-
Innate Pharma announces €22.5 million share offering
[BUSINESS] · 3 sources ·
-
Columbia Sportswear Raises Outlook on International Sales, Stock Drops After Stifel Downgrade
[BUSINESS] · 5 sources ·